Alzamend Neuro
2016
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Angel
LATEST DEAL TYPE
$232K
LATEST DEAL AMOUNT
Description
Developer of immunotherapeutic treatment and vaccine designed to treat Alzheimer's diseases. The company's immunotherapeutic treatment and vaccines are cell based therapeutic vaccines which are considered as as an immunotherapy to prevent or slow down Alzheimer's diseases, enabling patients to recover Alzheimer's diseases.
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 3802 Spectrum Boulevard
- Suite 112C
- Tampa, FL 33612
- United States
+1 (844) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Alzamend Neuro’s full profile, request a free trial.
Alzamend Neuro Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Angel (individual) | 19-Apr-2019 | $232K | 00.000 | Completed | Generating Revenue | |
| 2. Angel (individual) | 22-Aug-2017 | Cancelled | Generating Revenue | |||
| 1. Angel (individual) | 01-Jul-2016 | $1M | $1M | Completed | Generating Revenue |
Alzamend Neuro Executive Team (2)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Philip Mansour | President, Board Member & Chief Executive Officer | ||
| Milton Ault III | Founder & Chairman |
Alzamend Neuro Board Members (3)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Milton Ault III | Self | Founder & Chairman | 000 0000 | |
| Philip Mansour | Alzamend Neuro | President, Board Member & Chief Executive Officer | 000 0000 | |
| William Horne | Alzamend Neuro | Board Member | 000 0000 |